Inhibitor development as switching full-lengthrecombinant FVIII to B-domain deleted recombinantFVIII in previously treated patients with hemophilia A:Taiwan’s experience

Chia-Yau Chang, S-H Chen, G-C Yeh, C-H Tsai , J-R Tsai, Y-L Liu

Research output: Contribution to journalSpecial issuepeer-review

Fingerprint

Dive into the research topics of 'Inhibitor development as switching full-lengthrecombinant FVIII to B-domain deleted recombinantFVIII in previously treated patients with hemophilia A:Taiwan’s experience'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry